Drug product
Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16
D-1150-2022
Product summary
- Event
- Event 90415
- Status
- Terminated
- Classification
- Class II
- Quantity
- 3,216 bottles
- Official record key
drug-enforcement:D-1150-2022
Official wording
Reason: Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.
Code information: Lots: M100070, M100239, Exp. 06/22, M100312, Exp.09/22, M100366, Exp.10/22
Distribution pattern: Product was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.
Derived failure modes
-
Potency or specification failure
Out of specification